DIMENSIONAL FUND ADVISORS LP - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 96 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$55,805,000
+112.5%
1,481,405
-4.0%
0.02%
+100.0%
Q4 2020$26,263,000
+253.1%
1,543,780
-2.5%
0.01%
+200.0%
Q3 2020$7,438,000
-27.0%
1,582,570
-5.3%
0.00%
-25.0%
Q2 2020$10,194,000
+149.0%
1,670,815
-7.3%
0.00%
+100.0%
Q1 2020$4,094,000
-47.5%
1,803,218
+6.1%
0.00%
-33.3%
Q4 2019$7,799,000
+16.6%
1,699,355
-1.5%
0.00%0.0%
Q3 2019$6,690,000
-36.3%
1,726,052
-0.9%
0.00%
-25.0%
Q2 2019$10,505,000
-52.7%
1,742,106
+5.0%
0.00%
-55.6%
Q1 2019$22,228,000
+61.0%
1,658,706
+11.8%
0.01%
+50.0%
Q4 2018$13,803,000
-29.8%
1,484,178
+5.0%
0.01%
-14.3%
Q3 2018$19,671,000
+4.6%
1,413,177
+18.8%
0.01%0.0%
Q2 2018$18,808,000
+5.1%
1,189,654
+14.2%
0.01%0.0%
Q1 2018$17,897,000
-16.2%
1,041,750
+6.9%
0.01%
-22.2%
Q4 2017$21,357,000
-40.1%
974,276
+11.8%
0.01%
-43.8%
Q3 2017$35,651,000
+33.1%
871,497
-2.0%
0.02%
+33.3%
Q2 2017$26,787,000
-20.6%
889,576
-4.7%
0.01%
-25.0%
Q1 2017$33,743,000
-19.9%
933,410
+11.0%
0.02%
-23.8%
Q4 2016$42,147,000
+7.4%
841,072
+12.5%
0.02%0.0%
Q3 2016$39,255,000
+101.3%
747,861
+58.6%
0.02%
+90.9%
Q2 2016$19,498,000471,5360.01%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 3,381,117$47,065,0004.14%
GREAT POINT PARTNERS LLC 1,647,753$22,937,0003.58%
Rock Springs Capital Management LP 598,000$8,324,0000.30%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 136,029$1,894,0000.14%
FOX RUN MANAGEMENT, L.L.C. 20,935$291,0000.13%
Hilltop Holdings Inc. 39,824$554,0000.12%
WEXFORD CAPITAL LP 112,700$1,569,0000.10%
OXFORD ASSET MANAGEMENT LLP 296,339$4,132,0000.09%
Vident Investment Advisory, LLC 133,272$1,855,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 90,000$1,253,0000.06%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders